Magle Chemoswed Holding AB Logo

Magle Chemoswed Holding AB

A CDMO serving the pharma and medical device industries from development to manufacturing.

MAGLE | ST

Overview

Corporate Details

ISIN(s):
SE0014401014 (+2 more)
LEI:
549300FNJZS6NGFB6M31
Country:
Sweden
Address:
Agneslundsvägen 27, 212 15 Malmö

Description

Magle Chemoswed Holding AB is a Contract Development and Manufacturing Organization (CDMO) serving the pharmaceutical and medical device industries. The company provides comprehensive services that support the entire product lifecycle, from initial development to commercial manufacturing. Core service areas include analytical development, process development, and solid-state chemistry. Its manufacturing operations are cGMP and ISO 13485 compliant, with specialized capabilities in lyophilization (freeze-drying), small-scale, semi-automated fill and finish services, and support for inhalation drug delivery systems. The company partners with clients to advance innovations from concept to finished product.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Magle Chemoswed Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Magle Chemoswed Holding AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Magle Chemoswed Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-01-21 Stig Lökke Pedersen Other Other 384,000 11,520,000.00 SEK
2024-12-11 Martin Lidgard Other Buy 4,211 136,436.40 SEK
2024-12-05 Martin Lidgard Other Buy 632 21,740.80 SEK
2024-12-02 Martin Lidgard Other Buy 5,000 163,900.00 SEK

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.